Therefore, the upregulation of K2P5.1 may strengthen the production of IL-10 in the natural Treg cells of IBD model mice, and the activation of K2P5.1 may improve the pathogenesis of IBD. The gene discussed is IL10; the disease is inflammatory bowel disease.